Skip to main content
Production in Australia)

PRODUCTS

OUR PRODUCTS

This information is intended for U.S. residents.

Here you will find a listing of our products available in the U.S.

Consumers should contact their healthcare professional for further advice.

AFLURIA® QUADRIVALENT, Influenza Vaccine Suspension for Intramuscular Injection 

AFLURIA® QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. AFLURIA QUADRIVALENT is approved for use in persons 6 months of age and older

MORE INFORMATION
 
FLUAD® QUADRIVALENT (Influenza Vaccine, Adjuvanted) Suspension for Intramuscular Injection 

FLUAD QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. FLUAD QUADRIVALENT is approved for use in persons 65 years of age and older. Approval is based on the immune response elicited by FLUAD QUADRIVALENT. Data demonstrating a decrease in influenza disease after vaccination with FLUAD QUADRIVALENT are not available.

MORE INFORMATION
FLUCELVAX® QUADRIVALENT (Influenza Vaccine) Suspension for Intramuscular Injection 

FLUCELVAX QUADRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. FLUCELVAX QUADRIVALENT is approved for use in persons 4 years of age and older. For children and adolescents 4 through 17 years of age, approval is based on the immune response elicited by FLUCELVAX QUADRIVALENT. Data demonstrating a decrease in influenza disease after vaccination of this age group with FLUCELVAX QUADRIVALENT are not available.

MORE INFORMATION

The trademarks marked ® are registered by Seqirus U.K. Limited or its affiliates in one or more jurisdictions, unless indicated otherwise.

For more information about our products:

If you are a healthcare professional, please click here.

Pregnancy Registry

Learn how you can participate in an observational research study for pregnant women who have been vaccinated with influenza vaccine products.
Learn more

Pandemic Response Solutions

As a global leader in influenza vaccine manufacturing, Seqirus offers a portfolio of pandemic vaccines and services which are tailored to rapid response.
Learn more

 

Important Safety Information for AFLURIA QUADRIVALENT

INDICATION

AFLURIA® QUADRIVALENT (Influenza Vaccine) is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. AFLURIA QUADRIVALENT is approved for use in persons 6 months of age and older.

CONTRAINDICATIONS

  • Severe allergic reactions (e.g., anaphylaxis) to any component of the vaccine including egg protein, or to a previous dose of any influenza vaccine.

WARNINGS AND PRECAUTIONS

  • If Guillain-Barré Syndrome (GBS) has occurred within 6 weeks of previous influenza vaccination, the decision to give AFLURIA QUADRIVALENT should be based on careful consideration of the potential benefits and risks.
  • Appropriate medical treatment and supervision must be available to manage possible anaphylactic reactions following administration of the vaccine.
  • Immunocompromised persons may have a diminished immune response to AFLURIA QUADRIVALENT.

ADVERSE REACTIONS

  • In adults 18 through 64 years, the most commonly reported injection-site adverse reaction when administered by needle and syringe was pain (≥40%). The most common systemic adverse events were myalgia and headache (≥20%).
  • In adults 65 years of age and older, the most commonly reported injection-site adverse reaction when administered by needle and syringe was pain (≥20%). The most common systemic adverse event was myalgia (≥10%).
  • In children 5 through 8 years, the most commonly reported injection-site adverse reactions when administered by needle and syringe were pain (≥50%), redness and swelling (≥10%). The most common systemic adverse event was headache (≥10%).
  • In children 9 through 17 years, the most commonly reported injection-site adverse reactions when administered by needle and syringe were pain (≥50%), redness and swelling (≥10%). The most common systemic adverse events were headache, myalgia, and malaise and fatigue (≥10%).
  • In children 6 months through 35 months of age, the most commonly reported injection-site reactions were pain and redness (≥ 20%).The most common systemic adverse events were irritability (≥ 30%), diarrhea and loss of appetite (≥ 20%).
  • In children 36 through 59 months of age, the most commonly reported injection site reactions were pain (≥ 30%) and redness (≥ 20%). The most commonly reported systemic adverse events were malaise and fatigue, and diarrhea (≥ 10%).

The safety experience with AFLURIA (trivalent formulation) is relevant to AFLURIA QUADRIVALENT because both vaccines are manufactured using the same process and have overlapping compositions:

  • In adults 18 through 64 years of age, the most commonly reported injection-site adverse reactions with AFLURIA (trivalent formulation) when administered by the PharmaJet Stratis Needle-Free Injection System were tenderness (≥80%), swelling, pain, redness (≥60%), itching(≥20%) and bruising (≥10%). The most common systemic adverse events were myalgia, malaise (≥30%), and headache (≥20%).

To report SUSPECTED ADVERSE REACTIONS, contact Seqirus at 1-855-358-8966 or VAERS at 1-800-822-7967 and http://vaers.hhs.gov.

Please see full prescribing information for AFLURIA QUADRIVALENT.

Important Safety Information for FLUAD

Consumer

What is FLUAD® (Influenza Vaccine, Adjuvanted)?

FLUAD is a vaccine that helps protect against the flu. FLUAD is for people aged 65 years and older. Vaccination with FLUAD may not protect all people who receive the vaccine.

Who should not get FLUAD?

You should not get FLUAD if you have had a severe allergic reaction to any of the ingredients in the vaccine in the past, including egg protein, or a severe reaction to a previous influenza vaccine.

Who may not be able to get FLUAD? Tell your health care provider if you:

  • Have ever had Guillain-Barré syndrome (severe muscle weakness) after getting a flu shot. The decision to give FLUAD should be made by your health care provider, based on careful consideration of the potential benefits and risks.

What if I have a weakened immune system?

Tell your health care provider if you have problems with your immune system, as your immune response to the vaccine may be reduced.

What are the most common side effects of FLUAD?

  • Pain or tenderness where you got the shot
  • Muscle aches
  • Headache
  • Fatigue

These are not all of the possible side effects of FLUAD. You can ask your health care provider for a complete list of possible side effects.

Ask your health care provider for advice about any side effects that concern you. You may report side effects to the Vaccine Adverse Events Reporting System (VAERS) by calling 1-800-822-7967 or by going to http://vaers.hhs.gov.

To report SUSPECTED ADVERSE REACTIONS, contact Seqirus at 1-855-358-8966 or VAERS at 1-800-822-7967 and http://vaers.hhs.gov.

Please see full prescribing information for FLUAD.

Important Safety Information for FLUCELVAX QUADRIVALENT

Consumer

What is FLUCELVAX® QUADRIVALENT (Influenza Vaccine)?

FLUCELVAX QUADRIVALENT is a vaccine that helps protect against influenza (flu). FLUCELVAX QUADRIVALENT is for people aged 4 and older. Vaccination with FLUCELVAX QUADRIVALENT may not protect all people who receive the vaccine.

Who should not get FLUCELVAX QUADRIVALENT?

You should not get FLUCELVAX QUADRIVALENT if you have had a severe allergic reaction to any of the ingredients in the vaccine

Who may not be able to get FLUCELVAX QUADRIVALENT? Tell your healthcare provider if you:

  • have ever had Guillain-Barré Syndrome (severe muscle weakness) after getting a flu shot
  • have ever fainted after receiving an injection

What if I have a weakened immune system?

Tell your healthcare provider if you have problems with your immune system, as your immune response to the vaccine may be less.

What are the most common side effects of FLUCELVAX QUADRIVALENT?

  • pain or redness where you got the shot
  • headache
  • tiredness
  • muscle aches
  • feeling unwell (malaise)

These are not all of the possible side effects of FLUCELVAX QUADRIVALENT. You can ask your healthcare provider for a complete list of possible side effects.

Ask your healthcare provider for advice about any side effects that concern you. You may report side effects to the Vaccine Adverse Events Reporting System (VAERS) by calling 1-800-822-7967 or by going to http://vaers.hhs.gov.

To report SUSPECTED ADVERSE REACTIONS, contact Seqirus at 1-855-358-8966 or VAERS at 1-800-822-7967 and http://vaers.hhs.gov.

Please see full prescribing information for FLUCELVAX QUADRIVALENT.

US/CORP/0919/0170